Estimating the budget impact of new technologies added to the National List of Health Services in Israel: Stakeholders' incentives for adopting a financial risk-sharing mechanism

Health Policy

Volumn 89, Issue 1, 2009, Pages 78-83

  Hammerman, Ariel ^a,b   Greenberg, Dan ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

Author keywords

Budget impact; Health technology; Israel; Priority setting; Resource allocation; Risk sharing

Indexed keywords

ARTICLE; BUDGET; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH SERVICE; ISRAEL; MEDICAL TECHNOLOGY; PROFIT; RESOURCE ALLOCATION;

BIOMEDICAL TECHNOLOGY; BUDGETS; COST SHARING; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH PRIORITIES; ISRAEL; MOTIVATION; RESOURCE ALLOCATION;

EID: 57149118642     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2008.05.006     Document Type: Article

References (14)

1. Rosen B. Health Care Systems in Transition: Israel (2003), European Observatory on Health Care Systems, Copenhagen
2. Chinitz D., Shalev C., Galai N., and Israeli A. The second phase of priority setting. Israel's basic basket of health services: the importance of being explicitly implicit. British Medical Journal 317 (1998) 1005-1007
3. Rabinovich M., Wood F., and Shemer J. Impact of new medical technologies on health expenditures in Israel 2000-07. International Journal of Technology Assessment in Health Care 23 (2007) 443-448
4. Shani S., Siebzehner M.I., Luxenburg O., and Shemer J. Setting priorities for the adoption of health technologies on a national level-the Israeli experience. Health Policy 54 (2000) 169-185
5. Shemer J., Morginstin T., Hammerman A., Luxenburg O., and Shani S. Promoting medical technologies in the national list of health services: 1995-2000. Harefuah 142 (2003) 82-86 [in Hebrew]
6. Shani S., and Yahalom Z. The Israeli model for managing the National List of Health Services in an era of limited resources. Law Policy 24 (2002) 133-147
7. Tamir O., Rabinovich M., and Shani M. Year 2006 update of the Israel National List of Health Services. Israel Medical Association Journal 8 (2006) 595-600
8. Siebzehner MI. Priority Setting in Medical Technology-evaluation of the Israeli Model (unpublished doctoral dissertation). Beer-Sheva: Department of Health Systems Management, Ben-Gurion University of the Negev; 2004 [in Hebrew].
9. Klang S.H., Hammerman A., and Liebermann N. Budget impact analysis as a basis for resource allocation, the Israeli experience. In: Halkin H., and Tal O. (Eds). Patients, physicians and pharma workshop (2006), The Israel National Institute for Health Policy Research 52-56
10. Hammerman A., Klang S.H., and Liebermann N. Trastuzumab use for metastatic breast cancer-is "median time to treatment failure" an accurate parameter for budget impact analysis?. Value in Health 9 (2006) A293 [Abstract]
11. UK Department of Health, Health Service Circular. Cost effective provision of disease modifying therapies for people with multiple sclerosis (HSC 2002/004) London; 2002.
12. Garber A.M., and McClellan M.B. Satisfaction guaranteed-"payment by results" for biologic agents. New England Journal of Medicine 357 (2007) 1575-1577
13. Zaric S.Z., and O'Brien B.J. Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget. Health Economics 14 (2005) 793-803
14. de Pouvourville G. Risk-sharing agreements for innovative drugs: a new solution to old problems?. European Journal of Health Economics 7 (2006) 155-157